Method of diagnosing cardiovascular disease

Details Method of diagnosing cardiovascular disease Method of diagnosing cardiovascular disease

2004-04-01

2010-02-16

Cook, Lisa V (Department: 1641)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007100, C435S007900, C435S007920, C436S501000, C436S517000, C514S075000

Reexamination Certificate

active

07662577

ABSTRACT:
A method of and kit for diagnosing cardiovascular disease in a human involves assessing the presence and/or concentration of antibodies to platelet activating factor (PAF) in a sample of body fluid of the human.

REFERENCES:
patent: 4444879 (1984-04-01), Foster et al.
patent: 5731208 (1998-03-01), Heinecke
patent: WO 87/05904 (1987-10-01), None
Muzya et al. (Immunologiya, 1997, vol. 6, pp. 9-11, Abstract Only).
Baldo et al, “A specific, sensitive, and high capacity immunoassay for PAF”. 1991). 26(12):1136-1139.
Barquinero, Jordi, et al “Antibodies Against Platelet-Activating Factor in Patients With Antiphospholipid Antibodies”. Lupus, vol. 3 (1994), pp. 55-58.
Frostegard et al, “Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension”, Hypertension, 29(1), pp. 40-44, 1997.
Frostegard et al, “Platelet-Activating Factor and Oxidized LDL Induce Immune Activation by a Common Mechanism”, Arteriosclerosis, 17(5), pp. 963-968, 1997.
Harris et al, 'Evaluation of the Anti-Cardiolipin Antibody Test: Report of an International Workshop held Apr. 4, 1986:, Clin. Exp Immunol, Apr. 1987, 68(1):215-222.
Hirashima Y et al, “Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers”. & ACTA Neurochir. (1995) 137(1-2):15-18. (Dialog Information Services, File 154, Medline, Dialog accession No. 08672149, Medline accession No. 96350619).
Karasawa et al, “Radioimmunoassay for platelet activating factor”. Lipids. (1991). 26(12):1126-1129.
Lemne et al, “Carotid Intima-Media Thickness and Plaque Borderline Hypertension” Stroke, 26(1); pp. 34-39; 1995.
Ostermann et al, “The degradation of platelet activating factor in serum and its discriminative value in atherosclerotic patients.” Thrombosis Research. (1998). 52:529-540.
Boggs, Will, “Chronic H. Pylori Infection Linked to Early Vascular Disease”, Society for Vascular Surgery. [online], [retrieved Jul. 5, 2005]. VascularWeb.org. Retrieved from Internet <URL:http://svs.vascularweb.org/—contribution—pages/medical—news—reuters/pag...> reprint of : J AM Coll Cardiol. (2005). 45:1219-1222.
Koh, Kian, et al, “T cell-mediated vascular dysfunction of human allografts results from IFN-γ dysregulation of NO synthase”. The Journal of Clinical Investigation. (Sep. 2004). 114(6):846-856.
A. Albertini, et al; “Cost/Benefit and Predictive Value of Radioimmunoassay”;Symposia of the Giovanni Lorenzini Foundation; vol. 18, pp. 23-27.

Affiliated with

Also associated with

Rating

Method of diagnosing cardiovascular disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of diagnosing cardiovascular disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing cardiovascular disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4165197